MUCUS RELIEF- guaifenesin 400 mg tablet 
TWIN MED LLC

----------

Mucus Relief - Guaifenesin 400 mg Tablets

Active ingredient (in each tablet)

Guaifenesin 400 mg

Purpose

Expectorant

Uses

Warnings

Ask a doctor before use if you have

When using this product

  • do not exceed recommended dosage
  • do not use for more than 7 days

Stop use and ask a doctor if

  • cough lasts for more than 7 days, recurs, or is accompanied by fever, rash, or persistent headache.

These could be signs of a serious condition.

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) immediately.

Directions

Adults and children 12 years of age and older: take 1 tablet every 4 hours with a full glass of water while symptoms persist. Do not exceed 6 doses in 24 hours.

Children under 12 years of age:do not use

Other information

Inactive ingredients

Colloidal Silicon Dioxide, Croscarmellose Sodium, Maltodextrin, Microcrystalline Cellulose, Polyvinyl Pyrrolidone, Stearic Acid

Questions?

call toll-free 1-844-912-4012

Manufactured for:

TwinMed LLC.

11333 Greenstone Ave

Santa Fe Springs, CA 90670

ProCureProducts.com

Principal Display Panel

Guai 400

MUCUS RELIEF 
guaifenesin 400 mg tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:55681-311
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
GUAIFENESIN (UNII: 495W7451VQ) (GUAIFENESIN - UNII:495W7451VQ) GUAIFENESIN400 mg
Inactive Ingredients
Ingredient NameStrength
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
MALTODEXTRIN (UNII: 7CVR7L4A2D)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
POVIDONE (UNII: FZ989GH94E)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
Product Characteristics
ColorwhiteScoreno score
ShapeOVALSize17mm
FlavorImprint Code G400
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:55681-311-03300 in 1 BOTTLE; Type 0: Not a Combination Product07/01/2022
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01207/01/2022
Labeler - TWIN MED LLC (009579330)

Revised: 3/2026
Document Id: 4dc83923-e74d-3466-e063-6294a90a4f7d
Set id: e31bd69f-97ab-9d99-e053-2995a90a580e
Version: 5
Effective Time: 20260324
 
TWIN MED LLC